MedPath

Feasibility of a Smartphone Application for Asthma Self-management

Not Applicable
Recruiting
Conditions
Asthma Chronic
Interventions
Device: Asthma SMART
Registration Number
NCT05572177
Lead Sponsor
University of South Florida
Brief Summary

The primary goal of this project is to determine the feasibility, acceptability, and adherence of a smartphone application for improving asthma self-management in a pilot randomized controlled trial (RCT). The app is specifically designed to appeal to adolescents. Adolescents with persistent asthma will be randomized to receive: 1) standard-of-care or 2) the self-management app in addition to standard-of-care. Feasibility will be assessed by the ability to recruit and retain subjects, technical barriers to implementation, and the appropriateness of the intervention among adolescents and providers. The acceptability of the intervention will be determined by appraising perceived usefulness, entertainment, and ease of use of the app. Adherence to usage of the app over a 6-month period will be assessed by examining the frequency of app usage and the features that were used, and the extent of data regarding self-management that was entered. A secondary objective is to obtain preliminary estimates of effectiveness of the app on clinical outcomes (ACT score, spirometry, CHSA-C, exacerbations, and medication adherence) relative to standard-of-care. It is hypothesized that the app will result in a high level of adherence and will be a feasible and acceptable intervention to improve self-management among adolescents with persistent asthma.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • At least 12 and less than 18 years at enrollment
  • Established mild, moderate, or severe persistent asthma with a diagnosis verified by clinic physicians
  • Speak English
  • Not planning on moving out of the Tampa Bay area during the trial period
  • Must have a suitable iPhone or Android device available to use with the app
Exclusion Criteria
  • Having mental or other development disorder that may make self-management of a chronic condition difficult
  • Having other chronic lung disease or one or more of the following disorders including cystic fibrosis, neuromuscular disease, immunodeficiency or autoimmune disorders, blindness or severe vision impairment that may interfere with the ability to use the mobile app
  • Having participated in the app development phase of the funded project

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Asthma SMARTAsthma SMARTSubjects randomized to the intervention arm will be provided with the app to download to their personal iPhone or Android smartphone. Subjects will be asked to use the app every day for 6 months.
Primary Outcome Measures
NameTimeMethod
Recruitment rate (number recruited per month)6 months

The recruitment rate will be defined as the total number of participants recruited divided by the number of months of recruitment to determine the approximate number of participants recruited in a single site per month.

Mean overall usability score obtained from the Health-ITUESAssessed at the end of the 6 month trial

The Health Information Technology Usability Evaluation Scale is a validated survey of usability of mobile health technology consisting of 20 questions each on a 5-point Likert scale with four subscale domains on impact, perceived usefulness, perceived ease of use, and user control. The total score is calculated as the average score across the domains with a value range from 1 to 5. Higher scores represent greater usability.

Average app usage per day6 months

Sustainability of app usage will be defined as the number of days each participant interacted with the app at least once divided by the total number of days in the trial. Interaction is defined as performing any activity in the app.

Technical feasibility (percentage of screened population)6 months

The percentage of the screened population that has a suitable smartphone and data plan or wi-fi access in order to use the app.

Adherence to app reminders (proportion of app reminders)6 months

Adherence to the app will be determined by examining the frequency of responses to app reminders. Adherence will be calculated as the number of activities completed in response to an app reminder divided by the total number of reminders received.

Retention rate (proportion that complete the 6-month trial)6 months

The retention rate will be calculated as the number of participants that complete the 6 month follow-up exam divided by the total number of participants randomized in the study.

Secondary Outcome Measures
NameTimeMethod
Change in ACT score from baseline to the 6-month end pointBaseline and 6 month end-point

The ACT test is a validated 5-question survey used to measure asthma control according to NHLBI guidelines. Total scores range from 5 to 25. Change will be calculated as the 6-month ACT score - baseline ACT score.

Trial Locations

Locations (1)

University of South Florida

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath